effects [qlco]
therapy, hormonal [topp]
Replacement [topp]
Lipid [lipd]
haemostatic [ortf]
Post [tmco]
Menopausal [phsf]
Renal Disease, End-Stage [dsyn]
Patients [podg]
Hormone replacement therapy [topp]
Known [qlco]
effects [qlco]
Various [irda]
atherosclerotic [ftcn]
Parameters [fndg]
General Population [popg]
Post-Menopause [orgf]
Women [popg]
Evaluate [ftcn]
effects [qlco]
Hormone replacement therapy [topp]
Renal Disease, End-Stage [dsyn]
Patients [podg]
Evaluated [ftcn]
Lipid [lipd]
Profile [lbpr]
Coagulation [ortf]
Fibrinolysis [phsf]
Marker [clna]
Plasma homocystine level [lbpr]
treatment [ftcn]
Methods [inpr]
Five [qnco]
Post-Menopause [orgf]
Women [popg]
Maintenance [acty]
Haemodialysis [topp]
Assigned [ftcn]
Hormone replacement therapy [topp]
Group [idcn]
N NOS [aapp, imft]
Control Group [grup]
N NOS [aapp, imft]
Age [orga]
Range [qnco]
Duration [tmco]
Haemodialysis [topp]
Range [qnco]
months [tmco]
Hormone replacement therapy [topp]
Group [idcn]
months [tmco]
Control Group [grup]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
mg% [qnco]
Combined [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
2 5 [qnco]
mg% [qnco]
GIVEN [cnce]
Daily [tmco]
weeks [tmco]
Hormone replacement therapy [topp]
Group [idcn]
Total Cholesterol [lbpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Fibrinogen [aapp, bacs, phsu]
Plasminogen antigen [imft]
activator 1 [gngm]
PAI-1 [aapp, bacs]
Tissue [tisu]
Plasminogen antigen [imft]
von Willebrand Factor [aapp, bacs, phsu]
Plasma [bdsu]
homocysteine [aapp, bacs]
Measured [qlco]
weeks [tmco]
Start [tmco]
Study [mnob]
Group [idcn]
baseline [bodm]
Values [qlco]
Hormone replacement therapy [topp]
Group [idcn]
weeks [tmco]
Hormone replacement therapy [topp]
Increased [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
P NOS [aapp, imft]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
MRT [geoa]
Decreased [qnco]
P NOS [aapp, imft]
Lp(a) [aapp, bacs]
P NOS [aapp, imft]
PAI-1 [aapp, bacs]
Tissue [tisu]
Plasminogen antigen [imft]
Concentrations [menp]
Reduced [qlco]
P NOS [aapp, imft]
P NOS [aapp, imft]
Values [qlco]
Total Cholesterol [lbpr]
Fibrinogen [aapp, bacs, phsu]
von Willebrand Factor [aapp, bacs, phsu]
homocysteine levels [lbpr]
Hormone replacement therapy [topp]
Conclusions [idcn]
Above [spco]
Suggest [idcn]
Hormone replacement therapy [topp]
Favorable [qlco]
effects [qlco]
Atherosclerosis [dsyn]
Parameters [fndg]
Post-Menopause [orgf]
Women [popg]
Renal Disease, End-Stage [dsyn]
General Population [popg]
Post-Menopause [orgf]
Women [popg]
